{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:13:56Z","timestamp":1770920036872,"version":"3.50.1"},"reference-count":87,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1517\/17460441.2011.547188","type":"journal-article","created":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T07:26:46Z","timestamp":1295681206000},"page":"205-217","source":"Crossref","is-referenced-by-count":6,"title":["Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis"],"prefix":"10.1517","volume":"6","author":[{"given":"Luigi","family":"Gennari","sequence":"first","affiliation":[{"name":"University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Policlinico Le Scotte, Viale Bracci 1, 53100 Siena, Italy ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Merlotti","sequence":"additional","affiliation":[{"name":"University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Policlinico Le Scotte, Viale Bracci 1, 53100 Siena, Italy ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Stolakis","sequence":"additional","affiliation":[{"name":"University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Policlinico Le Scotte, Viale Bracci 1, 53100 Siena, Italy ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranuccio","family":"Nuti","sequence":"additional","affiliation":[{"name":"University of Siena, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Policlinico Le Scotte, Viale Bracci 1, 53100 Siena, Italy ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,1,22]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2008.04.009"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60346-3"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2006.01.002"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml028"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208273270908"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.23.3.0465"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.11.024"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08657-9"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.156.13.1399"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0172-4"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1630379"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.11.097"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/B978-0-12-373884-4.00059-8","volume-title":"Principles of bone biology","author":"Pacifici R","year":"2008","unstructured":"Pacifici R. Mechanisms of estrogen action in bone. In: Bilezikian JP, Raisz LG, Martin TJ, editors, Principles of bone biology. 3rd edition. Elsevier, Inc., USA; 2008. p. 921-33","edition":"3"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0856"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra053077"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.07.006"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92592-1"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540170033029"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.13.1465"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-007-0010-4"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-12-200012190-00008"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520270033028"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030808"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1290.037"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.8.1042"},{"issue":"4","key":"e_1_3_1_28_1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/gme.0b013e31817b076a","article-title":"Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American menopause society","volume":"15","author":"The North American Menopause Society","year":"2008","unstructured":"The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American menopause society. Menopause 2008;15(4):584-602","journal-title":"Menopause"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2009.45.8.1410652"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.6.1.137"},{"key":"e_1_3_1_31_1","first-page":"4177","article-title":"Development of antiestrogens and their use in breast cancer (Eight Cain Memorial award lecture)","volume":"50","author":"Lerner LJ","year":"1990","unstructured":"Lerner LJ, Jordan VC. Development of antiestrogens and their use in breast cancer (Eight Cain Memorial award lecture). Cancer Res 1990;50:4177-89","journal-title":"Cancer Res"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357908809082124"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(99)00176-9"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022219"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto960103.x"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724050-00002"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.3.259"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712043372301"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.11.1747"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.637"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806132"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420220081009"},{"key":"e_1_3_1_43_1","first-page":"2197","article-title":"A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women","volume":"85","author":"Prestwood KM","year":"2000","unstructured":"Prestwood KM, Gunness M, Muchmore DB, A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. J Clin Endocrinol Metab 2000;85:2197-202","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1434-z"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980048b"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/ol006652"},{"key":"e_1_3_1_47_1","first-page":"1067","article-title":"Lasofoxifene (Pfizer)","volume":"6","author":"Gennari L","year":"2005","unstructured":"Gennari L. Lasofoxifene (Pfizer). Curr Opin Investig Drugs 2005;6:1067-78","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_1_48_1","first-page":"113","article-title":"Lasofoxifene: evidence of its therapeutic value in osteoporosis","volume":"4","author":"Gennari L","year":"2010","unstructured":"Gennari L, Merlotti D, De Paola V, Nuti R. Lasofoxifene: evidence of its therapeutic value in osteoporosis. Core Evid 2010;4:113-29","journal-title":"Core Evid"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S6083"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342040-00004"},{"key":"e_1_3_1_51_1","first-page":"246","article-title":"In vivo and in vitro metabolites of a next-generation selective estrogen receptor modulator, lasofoxifene, in humans","volume":"36","author":"Jhonson KA","year":"2004","unstructured":"Jhonson KA, Gardner MJ, Prakash C. In vivo and in vitro metabolites of a next-generation selective estrogen receptor modulator, lasofoxifene, in humans. Drug Metab Rev 2004;36:246","journal-title":"Drug Metab Rev"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(85)90049-4"},{"key":"e_1_3_1_53_1","article-title":"A single-dose pharmacokinetic study of lasofoxifene in japanese and caucasian postmenopausal women","volume":"19","author":"Gardner M","year":"2004","unstructured":"Gardner M, Nishizawa Y, Wei G, A single-dose pharmacokinetic study of lasofoxifene in japanese and caucasian postmenopausal women. J Bone Miner Res 2004;19:abstract M469","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005283280"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005282627"},{"key":"e_1_3_1_56_1","article-title":"Effect of food on the pharmacokinetics of lasofoxifene, in healthy postmenopausal women","volume":"19","author":"Moller R","year":"2004","unstructured":"Moller R, Fisher J, Taylor A, Effect of food on the pharmacokinetics of lasofoxifene, in healthy postmenopausal women. J Bone Miner Res 2004;19:abstract SU487","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G347"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005283278"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.4.5902"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.1.1"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1481"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.4.7408"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.4.765"},{"key":"e_1_3_1_64_1","first-page":"S273","article-title":"Comparison of the effects of bazedoxifene, raloxifene, lasofoxifene and risedronate, co-treatment on h-PTH-induced reversal of established osteopenia in ovariectomized rats [abstract SU387]","volume":"18","author":"Kharode YP","year":"2003","unstructured":"Kharode YP, Green PD, Marzolf JT, Comparison of the effects of bazedoxifene, raloxifene, lasofoxifene and risedronate, co-treatment on h-PTH-induced reversal of established osteopenia in ovariectomized rats [abstract SU387]. J Bone Miner Res 2003;18:S273","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_65_1","first-page":"8683","article-title":"LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model","volume":"61","author":"Cohen LA","year":"2001","unstructured":"Cohen LA, Pittman B, Wang CX, LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model. Cancer Res 2001;61:8683-8","journal-title":"Cancer Res"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.03.077"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20008"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20009"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20013"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.20010"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0890-6238(98)00006-9"},{"key":"e_1_3_1_72_1","unstructured":"Available from: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4381b1-01-FDA.pdf [Last accessed 20 September 2010]"},{"key":"e_1_3_1_73_1","unstructured":"Available from: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/08\/briefing\/2008-4381b1-02-Pfizer.pdf [Last accessed 20 September 2010]"},{"key":"e_1_3_1_74_1","article-title":"Lasofoxifene phase 2 and phase 3 clinical trial design and strategy","volume":"20","author":"Lee A","year":"2005","unstructured":"Lee A, Radecki D, Wolter K, Lasofoxifene phase 2 and phase 3 clinical trial design and strategy. J Bone Miner Res 2005;20:abstract M384","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_75_1","article-title":"Lasofoxifene phase 2 dose response analysis in postmenopausal women","volume":"20","author":"Day W","year":"2005","unstructured":"Day W, Martel J, Lee A. Lasofoxifene phase 2 dose response analysis in postmenopausal women. J Bone Miner Res 2005;20:abstract M385","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040707"},{"key":"e_1_3_1_77_1","first-page":"25S","article-title":"Lasofoxifene, a selective estrogen receptor modulator, improves objective measures of vaginal atrophy","volume":"103","author":"Portman DJ","year":"2004","unstructured":"Portman DJ, Moffett AH, Bachman GA, Lasofoxifene, a selective estrogen receptor modulator, improves objective measures of vaginal atrophy. Obstet Gynecol 2004;103:25S-6S","journal-title":"Obstet Gynecol"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000188736.69617.4f"},{"key":"e_1_3_1_79_1","article-title":"Lasofoxifene increased BMD of the spine and hip and decreased bone turnover markers in postmenopausal women with low or normal BMD","volume":"20","author":"McClung M","year":"2005","unstructured":"McClung M, Siris E, Cummings S, Lasofoxifene increased BMD of the spine and hip and decreased bone turnover markers in postmenopausal women with low or normal BMD. J Bone Miner Res 2005;20:abstract F429","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_80_1","article-title":"Extraskeletal effects of lasofoxifene on postmenopausal women","volume":"20","author":"Davidson M","year":"2005","unstructured":"Davidson M, Moffett A, Welty F, Extraskeletal effects of lasofoxifene on postmenopausal women. J Bone Miner Res 2005;20:abstract SA428","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808692"},{"key":"e_1_3_1_82_1","article-title":"Postmenopausal evaluation and risk reduction with lasofoxifene trial: 5-year gynecological outcomes","author":"Goldstein SR","year":"2010","unstructured":"Goldstein SR, Neven P, Cummings S, Postmenopausal evaluation and risk reduction with lasofoxifene trial: 5-year gynecological outcomes. Menopause 2010. [Epub ahead of print]","journal-title":"Menopause"},{"key":"e_1_3_1_83_1","article-title":"Comparison of the extraskeletal effects of lasofoxifene and raloxifene","volume":"19","author":"McClung M","year":"2004","unstructured":"McClung M, Portman D, Emkey R, Comparison of the extraskeletal effects of lasofoxifene and raloxifene. J Bone Miner Res 2004;19:abstract SA423","journal-title":"J Bone Miner Res"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000222332.31101.42"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000227337.73738.c9"},{"key":"e_1_3_1_86_1","unstructured":"European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use. Committee for Medicinal Products for Human Use summary of positive opinion for Fablyn. London 18 December 2008. Doc.Ref. EMEA\/CHMP\/609979\/2008"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9364-1"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0912847"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta9220"}],"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17460441.2011.547188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:21:51Z","timestamp":1770916911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17460441.2011.547188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,22]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1517\/17460441.2011.547188"],"URL":"https:\/\/doi.org\/10.1517\/17460441.2011.547188","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,22]]}}}